Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Phosphodiesterase-5/5-HT2B dual inhibitors abrogate completely fibrotic potential of human renal fibroblasts isolated from renal allograft rejection patients
저자 Akhilesh Jaiswal, Narayan Prasad, Vikas Agarwal, Mantabya Singh, Mohit Rai, Saurabh Chaturvedi
출판정보 2021; 2021(1):
키워드
초록 Objective: Renal fibroblasts were isolated from nephrectomy of control (n=3) and renal allograft rejection patients (n=3).  Fibroblasts were incubated with TGF-β1 (10 ng/ml) for 1 hour, later with TGF-β1 (10 ng/ml) and [Sildenafil (10µM) plus SB204741 (1µM)] for 24 hours (post-treatment strategy). In the pre-treatment strategy, fibroblasts were pre-treated with [Sildenafil (10 µM) plus SB204741 (1 µM)] for 1 hour and later with only TGF-β1 (10 ng/ml) for 24 hours. Similar strategies were followed for individual treatments of inhibitors. Real-time qPCR for pro-fibrotic genes, COL1A1, ACTA2, CTGF, and fibronectin1, and anti-fibrotic genes, TIMP1, MMP2 was performed.  Type 1 collagen and α-SMA proteins were examined by western blotting. Methods: In TGF-β1 stimulated fibroblasts, significant up-regulation of pro-fibrotic gene expression was observed, significantly reducing co-culture with PDE-5 plus 5-HT2B inhibitors. The ratio of anti-fibrotic genes (MMP2/TIMP1) was restored significantly. The expression of type 1 collagen was decreased significantly. Furthermore, near-complete amelioration of ACTA2, as well as α-SMA protein, was observed significantly (Table 1). Results: Dual inhibition combination of PDE-5 plus 5-HT2B inhibitors lead to near-complete attenuation of conversion of resident fibroblasts to myo-fibroblasts and thus may have the prospective for treatment of fibrosis of renal allograft rejection patients. Conclusions: Objective: Despite improvements in immunosuppressive therapy, long-term allograft survival after kidney transplantation remains as low as 50%. The primary cause of chronic allograft nephropathy is “interstitial fibrosis and tubular atrophy” (IF/TA). Serotonin (5-HT; 5-Hydroxytryptamine) produces extracellular matrix proteins in presence of TGF-β1 dependent manner. TGF-β1 activates resident fibroblasts, trans-differentiate into myo-fibroblasts, which is the hallmark of the pathogenesis of fibrosis. Here we evaluate the anti-fibrotic efficacy of phosphodiesterase-5 (PDE-5) inhibitor, Sildenafil, and 5-HT2B inhibitor, SB204741 in combination, on renal fibroblast isolated from renal allograft rejection patients. Methods: Renal fibroblasts were isolated from nephrectomy of control (n=3) and renal allograft rejection patients (n=3).  Fibroblasts were incubated with TGF-β1 (10 ng/ml) for 1 hour, later with TGF-β1 (10 ng/ml) and [Sildenafil (10µM) plus SB204741 (1µM)] for 24 hours (post-treatment strategy). In the pre-treatment strategy, fibroblasts were pre-treated with [Sildenafil (10 µM) plus SB204741 (1 µM)] for 1 hour and later with only TGF-β1 (10 ng/ml) for 24 hours. Similar strategies were followed for individual treatments of inhibitors. Real-time qPCR for pro-fibrotic genes, COL1A1, ACTA2, CTGF, and fibronectin1, and anti-fibrotic genes, TIMP1, MMP2 was performed.  Type 1 collagen and α-SMA proteins were examined by western blotting. Results: In TGF-β1 stimulated fibroblasts, significant up-regulation of pro-fibrotic gene expression was observed, significantly reducing co-culture with PDE-5 plus 5-HT2B inhibitors. The ratio of anti-fibrotic genes (MMP2/TIMP1) was restored significantly. The expression of type 1 collagen was decreased significantly. Furthermore, near-complete amelioration of ACTA2, as well as α-SMA protein, was observed significantly (Table 1). Conclusions: Dual inhibition combination of PDE-5 plus 5-HT2B inhibitors lead to near-complete attenuation of conversion of resident fibroblasts to myo-fibroblasts and thus may have the prospective for treatment of fibrosis of renal allograft rejection patients.
원문(PDF) PDF 원문보기
위로가기